The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine (Q34214868)

31 July 2017

title

The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine (English)

1 reference

31 July 2017

Janis Kuka

1

1 reference

31 July 2017

Reinis Vilskersts

2

1 reference

31 July 2017

Helena Cirule

3

1 reference

31 July 2017

Marina Makrecka

4

1 reference

31 July 2017

Osvalds Pugovics

5

1 reference

31 July 2017

Ivars Kalvinsh

6

1 reference

31 July 2017

Maija Dambrova

7

1 reference

31 July 2017

Edgars Liepinsh

8

1 reference

31 July 2017

publication date

8 September 2011

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

31 July 2017

published in

1 reference

31 July 2017

volume

17

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

215-222

1 reference

New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Carnitine, mitochondrial function and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Mildronate: cardioprotective action through carnitine-lowering effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

3-(2,2,2-Trimethylhydrazinium)propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Development and characterization of an animal model of carnitine deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Structure and function of carnitine acyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Cytochrome C effect on respiration of heart mitochondria: influence of various factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Effect of inhibiting carnitine biosynthesis on male rat sexual performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Cardiac effects of the extract and active components of radix stephaniae tetrandrae. II. Myocardial infarct, arrhythmias, coronary arterial flow and heart rate in the isolated perfused rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Effects of long-term mildronate treatment on cardiac and liver functions in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Regulation of gluconeogenesis by Krüppel-like factor 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Inhibition of carnitine acetyltransferase by mildronate, a regulator of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Effects of Ginkgo biloba extract on heart and liver mitochondrial functions: mechanism(s) of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Regulation of lipid flux between liver and adipose tissue during transient hepatic steatosis in carnitine-depleted rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Metabolic therapy for the treatment of ischemic heart disease: reality and expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

Disorders of carnitine transport and the carnitine cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411419502

21 January 2018

Identifiers

DOI

10.1177/1074248411419502

1 reference

31 July 2017

1 reference